Show simple item record

AuthorKrämer, Thomasdc.contributor.author
Date of accession2016-03-15T09:07:03Zdc.date.accessioned
Available in OPARU since2016-03-15T09:07:03Zdc.date.available
Year of creation2012dc.date.created
AbstractDuring surgical replacement of the aorta, perfusion of the aorta is interrupted, leading to ischemia of the vulnerable spinal cord with possible postoperative paraplegia. The damage is even aggravated by reperfusion injury after restarting blood flow. Erythropoetin has been shown to be cytoprotective, particularly in cases of ischemia reperfusion sequences. We tested wether a new carbamylated fusion protein consisting of erythropoetin and a human Fc fragment (cEPO-Fc) improves the postoperative function of the lower extremities if administered twice, before ischemia as well as in the early reperfusion period. Therefore, a porcine model of 30 minutes of aortic occlusion and 10 hours of reperfusion was employed. Animals were randomly assigned to a placebo and a cEPO-Fc group (each n = 9). During reperfusion, anaesthesia was reduced at certain time points to graduate limb movement as reaction to a pain stimulus. Additionally, transcranial motor-evoked potentials were measured. Furthermore, blood samples were taken to measure for concentrations of interleukin 6, tumor necrosis factor alpha and 8-isoprostane. Finally, spinal cord samples were collected for detection of necrosis (Nissl stain) and apoptosis (TUNEL and Bax immunohistochemistry) as well as detection of DNA damage (comet assay). We found significantly better motoric reactions within the cEPO-Fc group after 10 hours of reperfusion and, in addition, the amplitudes of motor-evoked potentials were higher at the same time point. Moreover, the rate of necrotic motor neurons in our histologic samples was lower after treatment with cEPO-Fc. Finally, there was a decreased concentration of 8-isoprostane, indicating reduced oxidative stress. In conclusion, cEPO-Fc showed a marked protective effect in our model of spinal cord ischemia. More research is necessary to assess wether this protection can also be shown within individuals with multiple medical conditions and not only in young and healthy organisms.dc.description.abstract
Languagededc.language.iso
PublisherUniversität Ulmdc.publisher
LicenseStandarddc.rights
Link to license texthttps://oparu.uni-ulm.de/xmlui/license_v3dc.rights.uri
KeywordAortenersatzdc.subject
KeywordAortenokklusiondc.subject
KeywordIschämie-Reperfusions-Schadendc.subject
KeywordIschämische Paraparesedc.subject
KeywordIschämische Paraplegiedc.subject
KeywordRückenmarkprotektiondc.subject
KeywordRückenmarksischämiedc.subject
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
MeSHAortic aneurysmadc.subject.mesh
MeSHIschemiadc.subject.mesh
MeSHParaplegiadc.subject.mesh
MeSHSpinal corddc.subject.mesh
TitlePrävention der ischämischen Querschnittlähmung durch ein carbamyliertes Fusionsprotein aus Erythropoetin und einem humanen Fc-Fragment bei Aortenokklusion am Schweinemodelldc.title
Resource typeDissertationdc.type
DOIhttp://dx.doi.org/10.18725/OPARU-2818dc.identifier.doi
PPN734865716dc.identifier.ppn
URNhttp://nbn-resolving.de/urn:nbn:de:bsz:289-vts-83429dc.identifier.urn
GNDAortenaneurysmadc.subject.gnd
GNDArterielle Dissektiondc.subject.gnd
GNDErythropoietindc.subject.gnd
FacultyMedizinische Fakultätuulm.affiliationGeneral
Date of activation2013-01-21T09:06:12Zuulm.freischaltungVTS
Peer reviewneinuulm.peerReview
Shelfmark print versionW: W-H 13.185uulm.shelfmark
DCMI TypeTextuulm.typeDCMI
VTS ID8342uulm.vtsID
CategoryPublikationenuulm.category
Bibliographyuulmuulm.bibliographie


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record